Tenon Medical, Inc. Announces Participation in Upcoming Conferences

Rhea-AI Summary

Tenon Medical, Inc. (NASDAQ:TNON) has announced its participation in two upcoming investment conferences. The Q4 Investor Summit will take place on November 14-15, 2022, with CEO Steven Foster and CFO Steven Van Dick presenting on November 15 at 9:30 a.m. Eastern Time. A webcast of this presentation will be available. The company will also participate in the Benchmark 11th Annual Discovery One-on-One Investor Conference on December 1, 2022. Management will be available for one-on-one meetings, and interested parties can contact investor relations.

LOS GATOS, CA / ACCESSWIRE / November 2, 2022 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a company transforming care for patients suffering with certain sacroiliac disorders, today announced management's participation in the following upcoming conferences:

• Q4 Investor Summit, November 14-15, 2022.
  • Steven Foster, Chief Executive Officer, and Steven Van Dick, Chief Financial Officer, will present at 9:30 a.m. Eastern Time on Wednesday, November 15^th. A webcast of the presentation will be available for viewing here.
• Benchmark 11^th Annual Discovery One-on-One Investor Conference, December 1, 2022.

Management will be available for one-on-one meetings at both conferences. To schedule time with management at these conferences, please contact the respective conference organizer or email Tenon's investor relations at tenon@mzgroup.us.

About Tenon Medical, Inc.

Tenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran™ SI Joint Fusion System that offers a novel, less invasive Inferior-Posterior approach to the SI joint using a single, robust titanium implant. The system features the Catamaran™ Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI joint along its longitudinal axis. With an entry that mimics SI joint injection, the surgical approach is direct to the joint and inferior to the wide and variable dorsal recess. The angle and trajectory of the Inferior-Posterior approach is designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Tenon is preparing a national launch of this system to address the greatly underserved market opportunity that exists in this space. For more information, please visit https://www.tenonmed.com/.

The Tenon Medical logo and Tenon Medical, are registered trademarks of Tenon Medical, Inc. Catamaran is a trademark of Tenon Medical, Inc.

Investor Contact:

Shannon Devine
MZ North America
203-741-8811
tenon@mzgroup.us

SOURCE: Tenon Medical, Inc.

View source version on accesswire.com:
https://www.accesswire.com/723577/Tenon-Medical-Inc-Announces-Participation-in-Upcoming-Conferences

FAQ

What conferences is Tenon Medical participating in November 2022?

Tenon Medical will participate in the Q4 Investor Summit on November 14-15 and the Benchmark 11th Annual Discovery One-on-One Investor Conference on December 1, 2022.

When will Tenon Medical present at the Q4 Investor Summit?

Tenon Medical will present on November 15, 2022, at 9:30 a.m. Eastern Time during the Q4 Investor Summit.

Who will represent Tenon Medical at the Q4 Investor Summit?

Steven Foster, CEO, and Steven Van Dick, CFO, will represent Tenon Medical at the Q4 Investor Summit.

How can I schedule a one-on-one meeting with Tenon Medical's management?

To schedule a one-on-one meeting with Tenon Medical's management, contact the conference organizer or email their investor relations at tenon@mzgroup.us.

What is the focus of Tenon Medical's products?

Tenon Medical focuses on developing medical devices for sacroiliac disorders, including a novel less invasive SI joint fusion system.